Search Options Stock News and Analysis

Endo CEO Retirement Dampens Earnings Beat

https://www.schaeffersresearch.com/content/news/2019/11/05/endo-ceo-retirement-dampens-earnings-beat

11/5/2019 10:37 AM

The shares of drugmaker Endo International PLC (NASDAQ:ENDP) are sliding this morning, following CEO Paul Campanelli's retirement, effective once a successor is named. This announcement has overshado...

Weight-Loss Drug Data Lifts Vivus Stock Above 200-Day

https://www.schaeffersresearch.com/content/news/2019/08/20/weight-loss-drug-data-lifts-vivus-stock-above-200-day

8/20/2019 3:15 PM

Stocks are trading lower today as Treasury yields cool. Among individual stocks making notable moves are pharmaceutical firms Endo International PLC (NASDAQ:ENDP) and Vivus, Inc. (NASDAQ:VVUS), as ...

3 Stocks Suffering From Analyst Bear Notes Today

https://www.schaeffersresearch.com/content/news/2019/05/13/3-stocks-suffering-from-analyst-bear-notes-today

5/13/2019 3:19 PM

China's tariff retaliation has stocks pacing toward their worst day in months. Also in focus this afternoon are Dublin-based Endo International PLC (NASDAQ:ENDP), investment management firm Invesco L...

Surging Drug Stock Has Room to Run

https://www.schaeffersresearch.com/content/analysis/2018/09/04/surging-drug-stock-has-room-to-run

9/4/2018 2:23 PM

Ireland-based drugmaker Endo International plc (NASDAQ:ENDP) has been on a torrid pace this summer, and earlier today nabbed a fresh annual high of $17.46. If history is any guide, though, the fun cou...

2 Pharma Stocks Spiraling on Reports of a Not-For-Profit Generic Drug Competitor

https://www.schaeffersresearch.com/content/news/2018/01/18/2-pharma-stocks-spiraling-on-reports-of-a-not-for-profit-generic-drug-competitor

1/18/2018 3:29 PM

Threats of a government shutdown have the Dow retreating from the record high set earlier -- and testing its newfound footing atop 26,000. This negative price action is not confined to blue chips, ei...

PEOPLE ALSO SEARCH FOR